Interferon plus ribavirin in chronic hepatitis C non-responders to recombinant alpha-interferon.


The aim of this study was to evaluate the most appropriate therapeutic protocol for patients with chronic hepatitis C not responding to a previous course of recombinant interferon alpha-2b (rIFN). Sixty patients were randomly assigned to two groups of 30 subjects each: group A was treated with double dose of the same type of rIFN (6 MU t.i.w.) plus… (More)


  • Presentations referencing similar topics